Skip to main content

Press film - New Treatment of Unusual Cancer Disease

Video   •   Maj 27, 2011 15:02 CEST

 
The European Medicines Agency’s (EMA) approval of Sutent (sunitinib malat) for treatment of pancreatic neuroendocrine tumors (NET) gives patients with this rare disease new hope. One of the leading global experts, Kjell Öberg, Professor of Endocrine Oncology at Uppsala University Hospital, reports on the first new treatment for these patients in 25 years.
Licens Creative Commons erkännande (?)
Videolängd 2:58